Consultant Neurologist. Co-Founder & CMO at Kneu Health. NHS Clinical Entrepreneur. Academy Med Sci FLIER. JR Fellow Queens College. Health Innovation & MedTech
📱Can smartphone-based monitoring improve care in #ParkinsonDisease and dementia?
At #AAN2026, @KinanMuhammed of @KneuHealth discussed how digital tools may help clinicians remotely track motor + cognitive changes, optimize treatment, and enable more proactive care 🧠
Read now: https://t.co/4gF31gen84
#Telehealth #Neurology #AANAM #Dementia
Our collaboration with @ESNEFT & @HealthInnovEast won the HSJ Digitising Patient Care Award! This highlights the incredible impact we're having in Parkinson’s care - empowering patients and improving outcomes. https://t.co/vrV3wPzYcX
#hsjawards2024#Parkinsons
ICYMI in last month's newsletter: Dr Kinan Muhammed, co-founder and CMO of @Neu_health, shared insights on how smartphones could help transform Parkinson's care and contribute to a deeper understanding of patients' symptoms.
Read the blog at https://t.co/YBWWoQFWyJ
Also... ⬇️⬇️
Co-Founder and CMO, Kinan Muhammed shares how @Neu_Health can remotely measure changes and predict clinical outcomes in Parkinson's and dementia at this year's @AANmember conference.
https://t.co/qCLKGw5lxZ
#Parkinsons#dementia#digitalhealth#healthtech
In London's Excel for @HETTShow 2023!
@Neu_Health are delighted to be exhibiting with the @AHSNNetwork.
To learn more about how we're making Parkinson's & dementia care accessible for all, find us on the Connect app & meet us in the Innovation Zone
#HETT23#digitalhealth#AHSN
Have a question about living with Parkinson’s Disease
Readers of the Summer 2023 @ParkinsonsUK Progress magazine can find expert information from @Neu_Health Chief Medical Officer Dr @KinanMuhammed
You can read more here: https://t.co/DM93OPLMYH
You’ll spot Kinan on page 24!
How can tech improve lives of those with Parkinson’s & Dementia?
At the recent @OxfordPDCentre event, watch @Neu_Health Co-Founder & Chief Medical Officer Dr @KinanMuhammed share how world-leading @UniofOxford research is used to improve patient outcomes: https://t.co/qX83HLNh38
At @Neu_Health we are developing a digital platform, using AI & ML, to enable clinicians to assess disease progression, improve condition management, reduce clinician burden & improve outcomes for people with #Parkinsons disease, #Dementia & other neurodegenerative conditions.
I am very pleased to announce my role as co-founder & Chief Medical Officer of @Neu_Health an exciting new healthtech spinout from the @UniofOxford dedicated to making the latest Parkinson's disease & dementia care accessible for all. I am joined by @CarolineCake3 as CEO.
We are developing a digital platform, using artificial intelligence and machine learning, to enable clinicians to assess disease progression, improve condition management, reduce clinician burden and ultimately improve outcomes.